Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia.
Emre DurcanSerbay OzkanHalil Ibrahim SaygiMevlut Tamer DincerOzge Polat KorkmazSerdar SahinCebrail KaracaCem SuluAlev Bakır KayıHande Mefkure OzkayaSinan TrabulusE E G MeydanlıNurhan SeyahiMustafa Sait GönenPublished in: Journal of diabetes (2022)
At the end of the follow-up period, male patients receiving SGLT2i had better DKD-related parameters and podocyturia levels compared to baseline and the control group. Our data support the notion that SGLT2i might have structural benefits for glomerular health.